Backbone-modified amylin derivatives: implications for amyloid inhibitor design and as template for self-assembling

Ronald C Elgersma1, George Posthuma, Dirk T S Rijkers

  • 1Department of Medicinal Chemistry and Chemical Biology, Utrecht Institute for Pharmaceutical Sciences, The Netherlands.